TREM1 and chronic obstructive pulmonary disease: Although clinical data remain limited, accumulating evidence positions TREM-1 as both a biomarker of disease progression and a potential therapeutic target for modulating macrophage-driven inflammation during stable and exacerbation phases of COPD.